EHA2026 | What are the updated 4-year results from the phase III DREAMM-7 trial in RRMM? episode artwork

EPISODE · Jun 24, 2026 · 5 MIN

EHA2026 | What are the updated 4-year results from the phase III DREAMM-7 trial in RRMM?

from Multiple Myeloma Hub

During the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the Multiple Myeloma Hub spoke with Vania Tietsche de Moraes Hungria, Clínica São Germano, São Paolo, BR. We asked, What are the updated 4-year results from the phase III DREAMM-7 trial in RRMM? This educational resource is independently supported by GSK. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Jun 24, 2026

Embed this episode

NOW PLAYING

EHA2026 | What are the updated 4-year results from the phase III DREAMM-7 trial in RRMM?

0:00 5:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Multiple Myeloma Hub?

This episode is 5 minutes long.

When was this Multiple Myeloma Hub episode published?

This episode was published on June 24, 2026.

Can I download this Multiple Myeloma Hub episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!